Quantifying the economic gains associated with COVID-19 vaccination in the Canadian population: A cost-benefit analysis
Canada Communicable Disease Report · 29.06.2023 · 49 (6) · 263-273
DOI: 10.14745/ccdr.v49i06a03 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canada Communicable Disease Report, online erschienen am 29.06.2023. Verfasst von Ashleigh R Tuite und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Immunization and Respiratory Infectious Diseases, Public Health Agency of Canada, Ottawa, ON. Die Arbeit wurde bisher 14-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Immunization and Respiratory Infectious Diseases, Public Health Agency of Canada, Ottawa, ON.
- Dalla Lana School of Public Health, University of Toronto, Toronto, ON.
- Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada, Saint-Hyacinthe, QC and Guelph, ON.
- Policy Research, Economics, and Analytics Unit, Strategic Policy Branch, Health Canada, Ottawa, ON.
- Institute of Health Economics, Edmonton, AB.
Zitieren
APA
Tuite, A. R., Ng, V., Ximenes, R., Diener, A., Rafferty, E., Ogden, N. H., & Tunis, M. (2023). Quantifying the economic gains associated with COVID-19 vaccination in the Canadian population: A cost-benefit analysis. Canada Communicable Disease Report, 49(6), 263-273. https://doi.org/10.14745/ccdr.v49i06a03
Vancouver
Tuite AR, Ng V, Ximenes R, Diener A, Rafferty E, Ogden NH, et al. Quantifying the economic gains associated with COVID-19 vaccination in the Canadian population: A cost-benefit analysis. Canada Communicable Disease Report. 2023;49(6):263-273. doi:10.14745/ccdr.v49i06a03
BibTeX
@article{Tuite2023,
author = {Tuite, Ashleigh R and Ng, Victoria and Ximenes, Raphael and Diener, Alan and Rafferty, Ellen and Ogden, Nicholas H and Tunis, Matthew},
title = {Quantifying the economic gains associated with COVID-19 vaccination in the Canadian population: A cost-benefit analysis},
journal = {Canada Communicable Disease Report},
year = {2023},
volume = {49},
number = {6},
pages = {263--273},
doi = {10.14745/ccdr.v49i06a03}
}
EUVIMED